Platelet aggregation pathway

Pharmacogenet Genomics. 2011 Aug;21(8):516-21. doi: 10.1097/FPC.0b013e3283406323.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Aryl Hydrocarbon Hydroxylases / genetics
  • Aspirin / pharmacology
  • Clopidogrel
  • Cyclooxygenase 1 / genetics
  • Cyclooxygenase 1 / metabolism
  • Cytochrome P-450 CYP2C19
  • Drug Resistance / genetics
  • Humans
  • Integrin beta3 / genetics
  • Integrin beta3 / metabolism
  • Metabolic Networks and Pathways / drug effects*
  • Metabolic Networks and Pathways / genetics*
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation / genetics*
  • Platelet Aggregation Inhibitors / pharmacology*
  • Platelet Membrane Glycoprotein IIb / genetics
  • Platelet Membrane Glycoprotein IIb / metabolism
  • Polymorphism, Single Nucleotide / genetics
  • Ticlopidine / analogs & derivatives
  • Ticlopidine / pharmacology

Substances

  • Integrin beta3
  • Platelet Aggregation Inhibitors
  • Platelet Membrane Glycoprotein IIb
  • Clopidogrel
  • Aryl Hydrocarbon Hydroxylases
  • CYP2C19 protein, human
  • Cytochrome P-450 CYP2C19
  • Cyclooxygenase 1
  • PTGS1 protein, human
  • Ticlopidine
  • Aspirin